|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-12-17
|
|
pubmed:abstractText |
We hypothesized that the aldosterone: renin ratio (ARR) predicts the antihypertensive response to mineralocorticoid receptor antagonist, spironolactone (SPIRO), when compared with bendroflumethiazide (BFZ).
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1473-5598
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
170-7
|
|
pubmed:dateRevised |
2010-12-30
|
|
pubmed:meshHeading |
pubmed-meshheading:20009770-Aldosterone,
pubmed-meshheading:20009770-Bendroflumethiazide,
pubmed-meshheading:20009770-Blood Pressure,
pubmed-meshheading:20009770-Cross-Over Studies,
pubmed-meshheading:20009770-Diuretics,
pubmed-meshheading:20009770-Drug Therapy, Combination,
pubmed-meshheading:20009770-Female,
pubmed-meshheading:20009770-Humans,
pubmed-meshheading:20009770-Hyperaldosteronism,
pubmed-meshheading:20009770-Hypertension,
pubmed-meshheading:20009770-Male,
pubmed-meshheading:20009770-Middle Aged,
pubmed-meshheading:20009770-Predictive Value of Tests,
pubmed-meshheading:20009770-Renin,
pubmed-meshheading:20009770-Spironolactone,
pubmed-meshheading:20009770-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO.
|
|
pubmed:affiliation |
Department of Cardiology, Papworth Hospital, Cambridge, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
